Security key
59935V107
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)
CUSIP: 59935V107
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 124,817,707
- Total 13F shares
- 14,399,976
- Share change
- +1,330,267
- Total reported value
- $230,543,150
- Price per share
- $16.01
- Number of holders
- 25
- Value change
- +$20,592,614
- Number of buys
- 12
- Number of sells
- 7
Report period
Q4 2019
Institutions
25
Top holders
10
MIST full security history
Newer quarter: Q1 2020
Previous quarter: Q3 2019
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59935V107
Recent filing periods:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
2.8%
|
3,521,856
|
$63,819,000 | — | 30 Sep 2019 | |
| Novo Holdings A/S |
13F
|
Company |
2.1%
|
2,674,470
|
$49,879,000 | — | 30 Sep 2019 | |
| VHCP Management III, LLC |
13F
|
Company |
1.7%
|
2,066,529
|
$38,541,000 | — | 30 Sep 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
1,300,646
|
$22,501,000 | — | 30 Sep 2019 | |
| Boxer Capital, LLC |
13F
|
Company |
0.88%
|
1,102,194
|
$20,556,000 | — | 30 Sep 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.4%
|
500,000
|
$9,325,000 | — | 30 Sep 2019 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.3%
|
369,500
|
$6,891,000 | — | 30 Sep 2019 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
325,000
|
$6,061,000 | — | 30 Sep 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.21%
|
266,667
|
$4,973,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
0.19%
|
239,600
|
$4,145,000 | — | 30 Sep 2019 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.19%
|
235,000
|
$4,383,000 | — | 30 Sep 2019 | |
| Zimmer Partners, LP |
13F
|
Company |
0.13%
|
160,000
|
$2,984,000 | — | 30 Sep 2019 | |
| VHCP Management II, LLC |
13F
|
Company |
0.12%
|
148,560
|
$2,771,000 | — | 30 Sep 2019 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.04%
|
46,940
|
$812,000 | — | 30 Sep 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
36,265
|
$627,000 | — | 30 Sep 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.02%
|
26,097
|
$451,000 | — | 30 Sep 2019 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.02%
|
25,000
|
$466,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
23,704
|
$410,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
700
|
$13,000 | — | 30 Sep 2019 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
500
|
$9,000 | — | 30 Sep 2019 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
280
|
$5,222 | — | 30 Sep 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
149
|
$3,000 | — | 30 Sep 2019 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
0%
|
52
|
$1,000 | — | 30 Sep 2019 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) as of Q4 2019
As of 31 Dec 2019,
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,399,976 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Novo Holdings A/S, VHCP Management III, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BOXER CAPITAL, LLC, Tekla Capital Management LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACUTA CAPITAL PARTNERS, LLC, ORBIMED ADVISORS LLC, and Invesco Ltd..
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
23
Q4 2019 holders
25
Holder diff
2
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.